Unjha Formulations Q3 Results
- BSE: 531762
- NSE: -
- ISIN: INE576D01015
- Sector: Biotechnology & Drugs
BSE
22.61
-0.24 (-1.05%)
-0.24 (-1.05%)Volume1.05 K
Updated: Fri 13 Jun, 2025 | 15:23:47
NSE
This stock is not traded on NSE
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q3 Results Highlights
Note: Comparison is on QoQ basis
Quarterly - Unjha Formulations Q3 Results
*All figures in crores except per share values
| Fiscal Period | Dec 24 | Sep 24 | QoQ Comp | Dec 23 | YoY Comp |
|---|---|---|---|---|---|
| Total Revenue | 3.76 | 3.78 | -0.52% | 5.55 | -32.15% |
| Selling/ General/ Admin Expenses Total | 0.20 | 0.12 | 58.43% | 0.19 | 3.32% |
| Depreciation/ Amortization | 0.02 | 0.02 | 1.78% | 0.02 | 18.04% |
| Other Operating Expenses Total | 0.35 | 0.37 | -5.35% | 0.49 | -28.32% |
| Total Operating Expense | 3.55 | 3.91 | -9.38% | 5.15 | -31.18% |
| Operating Income | 0.22 | -0.13 | 0.00% | 0.39 | -45.03% |
| Net Income Before Taxes | 0.22 | -0.11 | 0.00% | 0.39 | -42.33% |
| Net Income | 0.22 | -0.11 | 0.00% | 0.39 | -42.33% |
| Diluted Normalized EPS | 0.50 | -0.25 | 0.00% | 0.87 | -42.32% |